Use of the novel anticoagulant otamixaban did not reduce ischemic events compared with unfractionated heparin plus eptifibatide but increased bleeding among patients with non–ST-segment elevation acute coronary syndromes ...
Sep 1, 2013
0
0
(HealthDay)—More than 20 percent of young non-athletes have electrocardiogram (ECG) patterns that can be considered potentially pathological based on the 2010 European Society of Cardiology position paper, according to ...
Mar 6, 2014
0
0
Colchicine does not significantly reduce perioperative atrial fibrillation (AF) or myocardial injury after non-cardiac surgery (MINS) in patients undergoing major non-cardiac thoracic surgery, according to late breaking research ...
Aug 25, 2023
0
1
Experts in emergency cardiac care from around the world met in Istanbul to discuss ways to improve outcomes in patients with acute cardiac disease. This was the first annual meeting of the newly launched Acute Cardiovascular ...
Oct 22, 2012
0
0
The European Society of Cardiology (ESC), which represents more than 100,000 health care professionals, today urges EU health ministers to prevent a shortfall of essential medical devices for cardiovascular patients.
Dec 7, 2022
0
23
Patients with type 2 diabetes and high cardiovascular risk due to recent acute coronary syndromes had similar rates of cardiovascular events when treated with the anti-diabetic agent alogliptin compared to placebo according ...
Sep 2, 2013
0
0
A long-term study of children with a complex heart condition called hypertrophic cardiomyopathy (HCM) found that the risk of death or need for immediate listing for heart transplantation was greatest for those who developed ...
Sep 3, 2013
0
0
While ensuring the safety of high school and college athletes is hardly controversial, the method and associated costs of doing so are hotly debated. Conducting electrocardiographic (ECG) screenings of all young competitive ...
Nov 26, 2012
0
0
Cardiovascular disease (CVD) cost the EU an estimated €282 billion in 2021, according to late breaking research presented at ESC Congress 2023. Health and long-term care accounted for €155 billion (55%) of these costs, ...
Aug 28, 2023
0
1
The impact of industrially produced trans fatty acids (TFAs) on the health of citizens in the European Union (EU) will be debated today by Members of the European Parliament (MEPs), representatives of the European Commission ...
Apr 14, 2015
0
6
